Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

BACKGROUND: Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors (ICIs). Myocarditis is an uncommon but serio...

Descripción completa

Detalles Bibliográficos
Autores principales: Awadalla, Magid, Golden, Doll Lauren Alexandra, Mahmood, Syed S., Alvi, Raza M., Mercaldo, Nathaniel D., Hassan, Malek Z. O., Banerji, Dahlia, Rokicki, Adam, Mulligan, Connor, Murphy, Sean P. T., Jones-O’Connor, Maeve, Cohen, Justine V., Heinzerling, Lucie M., Armanious, Merna, Sullivan, Ryan J., Damrongwatanasuk, Rongras, Chen, Carol L., Gupta, Dipti, Kirchberger, Michael C., Moslehi, Javid J., Shah, Sachin P., Ganatra, Sarju, Thavendiranathan, Paaladinesh, Rizvi, Muhammad A., Sahni, Gagan, Lyon, Alexander R., Tocchetti, Carlo G., Mercurio, Valentina, Thuny, Franck, Ederhy, Stephane, Mahmoudi, Michael, Lawrence, Donald P., Groarke, John D., Nohria, Anju, Fradley, Michael G., Reynolds, Kerry L., Neilan, Tomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387531/
https://www.ncbi.nlm.nih.gov/pubmed/30795818
http://dx.doi.org/10.1186/s40425-019-0535-y

Ejemplares similares

Ejemplares similares